Jump to content

Vaccines

Vaccine Discovery

Vaccine Discovery

Designed to increase the efficiency and quality of vaccine discovery, the purpose-built, end-to-end enterprise platform supports the full discovery process and enables faster testing, simplified production, and reduced costs. In addition to classical vaccine R&D approaches, it supports novel vaccine technologies such as synthetic self-amplifying mRNA, which accelerates vaccine development by utilizing synthetic and cell-free processes. Genedata Biologics paves the way for the discovery of novel vaccines, even for antigens that are extremely difficult to produce and formulate.

Learn More
Vaccine Discovery

Novel mRNA Vaccines

Designed to increase the efficiency and quality of vaccine discovery, the purpose-built, end-to-end enterprise platform supports the full discovery process and enables faster testing, simplified production, and reduced costs. In addition to classical vaccine R&D approaches, it supports novel vaccine technologies such as synthetic self-amplifying mRNA, which accelerates vaccine development by utilizing synthetic and cell-free processes. Genedata Biologics paves the way for the discovery of novel vaccines, even for antigens that are extremely difficult to produce and formulate.

Learn More